Abstract:Cellular immune responses play a key role in the control of viral infection. The nucleocapsid (N) protein of infectious bronchitis virus (IBV) is a major immunogenic protein that can induce protective immunity. To screen for potential T-cell epitopes on IBV N protein, forty overlapping peptides covering the entirety of the N protein were designed and synthesized. Four T-cell epitope peptides were identified by IFN-γ ELISpot, intracellular cytokine staining, and CFSE lymphocyte proliferation assays; among them, three peptides (N 211–230 , N 271–290 , and N 381–400 ) were CTL epitopes, and one peptide (N 261–280 ) was a dual-specific T-cell epitope, which can be recognized by both CD8 + and CD4 + T cells. Multi-epitope gene transcription cassettes comprising four neutralizing epitope domains and four T-cell epitope peptides were synthesized and inserted into the genome of Newcastle disease virus strain La Sota between the P and M genes. Recombinant IBV multi-epitope vaccine candidate rLa Sota/SBNT was generated via reverse genetics, and its immune protection efficacy was evaluated in specific-pathogen-free chickens. Our results show that rLa Sota/SBNT induced IBV-specific neutralizing antibody and T-cell responses and provided significant protection against homologous and heterologous IBV challenge. Thus, the T-cell epitope peptides identified in this study could be good candidates for IBV vaccine development, and recombinant Newcastle disease virus expressing IBV multi-epitope genes represents a safe and effective vaccine candidate for controlling infectious bronchitis. IMPORTANCE T-cell-mediated immune responses are critical for the elimination of IBV-infected cells. To screen conserved T-cell epitopes in the IBV N protein, forty overlapping peptides covering the entirety of the N protein were designed and synthesized. By combining IFN-γ ELISpot, intracellular cytokine staining, and CFSE lymphocyte proliferation assays, we identified three CTL epitopes and one dual-specific T-cell epitope. The value of T-cell epitope peptides identified in the N protein was further verified by the design of an IBV multi-epitope vaccine. Results show that IBV multi-epitope vaccine candidate rLa Sota/SBNT provided cross protection against challenges with a QX-like or a TW-like IBV strain. So T-cell-mediated immune responses play an important role in the control of viral infection and conserved T-cell epitopes serve as promising candidates for use in multi-epitope vaccine construction. Our results provide a new perspective for the development of a safer and more effective IBV vaccine.

Greater Protection against Virulent Infectious Bronchitis Virus Challenge Conferred by Recombinant Baculovirus Co-expressing S1 and N Proteins

Protection Against Virulent Infectious Bronchitis Virus Challenge Conferred By A Recombinant Baculovirus Co-Expressing S1 And N Proteins

Development and Characterization of a Recombinant Infectious Bronchitis Virus Expressing the Ectodomain Region of S1 Gene of H120 Strain.

Establishment and Cross-Protection Efficacy of a Recombinant Avian Gammacoronavirus Infectious Bronchitis Virus Harboring a Chimeric S1 Subunit

Protective immune responses induced by in ovo immunization with recombinant adenoviruses expressing spike (S1) glycoprotein of infectious bronchitis virus fused/co-administered with granulocyte-macrophage colony stimulating factor.

Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens

Construction and Immunogenicity Comparison of Three Virus-Like Particles Carrying Different Combinations of Structural Proteins of Avian Coronavirus Infectious Bronchitis Virus.

Immunogenicity and Protective Efficacy of Recombinant Fusion Proteins Containing Spike Protein of Infectious Bronchitis Virus and Hemagglutinin of H3N2 Influenza Virus in Chickens.

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV

Recombinant Vp2 Protein of Infectious Bursal Disease Virus AH1 Strain Expressed in Insect Cells: a Vaccine Candidate

Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus.

Immunogenicity Evaluaton of S1 Glycoproteins from Infectious Bronchitis Virus Isolates JS/95/03 and SD/97/01 Expressed by Recombinant Baculoviruses

Assembly and Immunogenicity of Baculovirus-Derived Infectious Bronchitis Virus–like Particles Carrying Membrane, Envelope and the Recombinant Spike Proteins

Preparation of ChIL-2 and IBDV VP2 Fusion Protein by Baculovirus Expression System

Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine

A Recombinant baculovirus expressing VP2 protein of infectious bursal disease virus (IBDV) and chicken interleukin-18 (ChiL-18) protein protects against very virulent IBDV

Construction And Immunogenicity Of Novel Chimeric Virus-Like Particles Bearing Antigens Of Infectious Bronchitis Virus And Newcastle Disease Virus

Multivalent Dna Vaccine Enhanced Protection Efficacy Against Infectious Bronchitis Virus In Chickens

Development and Immunoprotection of Bacterium-like Particle Vaccine Against Infectious Bronchitis in Chickens.

Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge

Efficacy of a plant-produced infectious bronchitis virus-like particle vaccine in specific pathogen-free chickens